Central and systemic C-type Natriuretic Peptide are both reduced in Parkinson's Disease

Plasma concentrations of amino-terminal proCNP are depressed in PD, are likely to result from diminished reabsorption from central sources, and may be useful in monitoring onset and effects of therapeutic interventions in PD.